Interrater and Intrarater Reliability of Mohs Surgeons in the Assessment of MART-1 Frozen Section Margins for Melanoma

Dermatol Surg. 2026 May 1;52(5):421-427. doi: 10.1097/DSS.0000000000004906. Epub 2025 Oct 8.

Abstract

Background: The use of Mohs micrographic surgery as a treatment for melanoma is rising, but the reliability of Mohs surgeons in assessing MART-1 melanoma en-face margins has not been evaluated.

Objective: To evaluate interrater and intrarater reliability of Mohs surgeons in interpreting margins of early-stage melanoma.

Methods: Twenty Mohs surgeons were asked to independently review images of frozen section MART-1 en-face peripheral margins of in situ or early-stage melanoma. Surgeons determined margins as positive or negative at initial evaluation and 6 weeks later. Primary outcomes were interrater and intrarater reliability.

Results: Interrater agreement was 84.1% (95% confidence interval [CI]: 75.5%-92.8%) for assessment 1 and 87.5% (95% CI: 78.4%-96.4%) for assessment 2, with kappa values 0.68 (95% CI: 0.50-0.82) and 0.75 (95% CI: 0.57-0.88). Average intrarater percent agreement was 95.0% (95% CI: 70.6%-100.0%) with average kappa 0.90 (95% CI: 0.50-1.00).

Conclusion: Substantial interrater and nearly perfect intrarater agreement was identified among surgeons assessing melanoma margins utilizing MART-1 immunostaining, demonstrating consistent and reproducible assessment of melanoma margins during Mohs cases.

MeSH terms

  • Frozen Sections
  • Humans
  • MART-1 Antigen* / analysis
  • Male
  • Margins of Excision*
  • Melanoma* / pathology
  • Melanoma* / surgery
  • Mohs Surgery*
  • Observer Variation
  • Reproducibility of Results
  • Skin Neoplasms* / pathology
  • Skin Neoplasms* / surgery
  • Surgeons* / statistics & numerical data

Substances

  • MART-1 Antigen